From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Webinar April 9, 2024 at 1:00 PM EST
Do you capitalize on all the Contracts & Pricing insights delivered by ICyte? We have found that most manufacturers do not fully tap into the value ICyte delivers. Our Contracts & Pricing Analytics SMEs will walk you through the business cases for some of the most valuable analytics as well as the ICyte Payment Portal.
We’ll dive into trend analysis to identify invoices that are outside the norm, the ability to analyze claims to understand why they should be excluded, as well as understand which products and customers are driving your sales.
Our experts Jon Brier and Brenda Mulligan will answer your questions during the webinar on April 9.
Jon BrierExecutive Director, GTN/C&P
Brenda MulliganExecutive Director, Rebate Operations
